BR112015031977A2 - gel biocompatível, e, kit - Google Patents

gel biocompatível, e, kit

Info

Publication number
BR112015031977A2
BR112015031977A2 BR112015031977A BR112015031977A BR112015031977A2 BR 112015031977 A2 BR112015031977 A2 BR 112015031977A2 BR 112015031977 A BR112015031977 A BR 112015031977A BR 112015031977 A BR112015031977 A BR 112015031977A BR 112015031977 A2 BR112015031977 A2 BR 112015031977A2
Authority
BR
Brazil
Prior art keywords
nanoparticle
kit
nanoparticles
gel
biocompatible
Prior art date
Application number
BR112015031977A
Other languages
English (en)
Inventor
Pottier Agnès
Berjaud Céline
Poul Laurence
Levy Laurent
Germain Matthieu
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of BR112015031977A2 publication Critical patent/BR112015031977A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0457—Semi-solid forms, ointments, gels, hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

resumo gel biocompatível, e, kit a presente invenção se refere a composições e métodos para uso em diagnóstico médico e monitoramento de pacientes. refere-se, mais particularmente, a um gel biocompatível que compreende nanopartículas e/ou agregados de nanopartículas, em que i) a nanopartícula e/ou o agregado de nanopartículas compreende um material inorgânico que compreende pelo menos um elemento metálico que tem um número atômico z de pelo menos 25, sendo que cada um dentre a dita nanopartícula e o dito agregado de nanopartículas está coberto por um revestimento biocompatível; ii) a concentração de nanopartículas e/ou agregados de nanopartículas é de cerca de ou menos do que 0,5 % (p/p); e iii) a viscosidade aparente a 2s-1 do gel que compreende nanopartículas e/ou agregados de nanopartículas está entre cerca de 0,1 pa.s e cerca de 1000 pa.s quando medida entre 20 °c e 37 °c. a composição da invenção permite tipicamente o delineamento e a visualização de pelo menos 40 % do tecido-alvo biológico quando o dito tecido é observado com o uso de um equipamento de imageamento de raios x. 1/1
BR112015031977A 2013-06-20 2014-06-19 gel biocompatível, e, kit BR112015031977A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361837389P 2013-06-20 2013-06-20
EP13305831 2013-06-20
PCT/EP2014/062947 WO2014202723A1 (en) 2013-06-20 2014-06-19 Compositions and methods for use in medical diagnosis

Publications (1)

Publication Number Publication Date
BR112015031977A2 true BR112015031977A2 (pt) 2017-07-25

Family

ID=48745869

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015031977A BR112015031977A2 (pt) 2013-06-20 2014-06-19 gel biocompatível, e, kit

Country Status (14)

Country Link
US (1) US10588987B2 (pt)
EP (1) EP3010495B1 (pt)
JP (1) JP6560665B2 (pt)
KR (1) KR20160027009A (pt)
CN (1) CN105431141A (pt)
AU (1) AU2014283217A1 (pt)
BR (1) BR112015031977A2 (pt)
CA (1) CA2915430A1 (pt)
EA (1) EA201690050A1 (pt)
HK (1) HK1222562A1 (pt)
MA (1) MA38709A1 (pt)
MX (1) MX2015017774A (pt)
SG (1) SG11201510021TA (pt)
WO (1) WO2014202723A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6042450B2 (ja) 2011-12-16 2016-12-14 ナノビオティックスＮａｎｏｂｉｏｔｉｘ 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用
US11096962B2 (en) 2015-05-28 2021-08-24 Nanobiotix Nanoparticles for use as a therapeutic vaccine
CN105097174B (zh) * 2015-08-12 2018-06-22 华南理工大学 一种木聚糖季铵盐纳米磁性颗粒及其制备方法
MX2019007614A (es) 2016-12-21 2019-09-04 Nanobiotix Nanoparticulas para su uso para tratar un trastorno neuronal.
WO2018114988A1 (en) 2016-12-21 2018-06-28 Nanobiotix Nanoparticles for use for enhancing brain performances or for treating stress
KR101949347B1 (ko) * 2017-05-24 2019-02-18 이화여자대학교 산학협력단 유방암의 재발 예측을 위한 정보제공방법
US11116793B2 (en) * 2017-11-13 2021-09-14 National University Corporation Hokkaido University Modified metal nanoparticle comprising cyclic polyether and pharmaceutical composition
CN107998395A (zh) * 2017-12-14 2018-05-08 天津市赛宁生物工程技术有限公司 一种双功能乳腺靶标及制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6161034A (en) 1999-02-02 2000-12-12 Senorx, Inc. Methods and chemical preparations for time-limited marking of biopsy sites
US20050084869A1 (en) * 2003-10-20 2005-04-21 Sung Hyun Kim Novel composition and methods for the diagnosis of lung cancer
FR2869803B1 (fr) * 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
DE102006041495A1 (de) 2006-08-29 2008-03-20 Friedrich-Schiller-Universität Jena Substanzgemisch zur lokalen Deposition von Magnetpartikeln in einem Medium, insbesondere in tumorbefallenem organischem Gewebe, sowie Applikationskit zur Verabreichung
DE102008008522A1 (de) * 2008-02-11 2009-08-13 Magforce Nanotechnologies Ag Implantierbare Nanopartikel-enthaltende Produkte
EP2130553A1 (en) 2008-06-05 2009-12-09 Nanobiotix Inorganic nanoparticles of high density to destroy cells in-vivo
EP2275137A1 (en) * 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
EP2512540B1 (en) 2009-12-15 2019-08-07 Incept, LLC Implants and biodegradable fiducial markers
WO2013076305A1 (en) 2011-11-25 2013-05-30 Danmarks Tekniske Universitet Formulation of solid nano-sized particles in a gel-forming system
JP6042450B2 (ja) * 2011-12-16 2016-12-14 ナノビオティックスＮａｎｏｂｉｏｔｉｘ 金属材料および酸化ハフニウム材料を含むナノ粒子、その製造および使用
WO2014121224A2 (en) * 2013-02-01 2014-08-07 The Trustees Of Dartmouth College Biodegradable iron oxide nanoparticle gel for tumor bed therapy
WO2014202738A1 (en) * 2013-06-20 2014-12-24 Nanobiotix Compositions and methods for use in oncology

Also Published As

Publication number Publication date
CN105431141A (zh) 2016-03-23
MX2015017774A (es) 2016-03-31
EP3010495A1 (en) 2016-04-27
KR20160027009A (ko) 2016-03-09
JP6560665B2 (ja) 2019-08-14
US10588987B2 (en) 2020-03-17
JP2016527204A (ja) 2016-09-08
HK1222562A1 (zh) 2017-07-07
CA2915430A1 (en) 2014-12-24
EP3010495B1 (en) 2021-06-16
AU2014283217A1 (en) 2015-12-24
MA38709A1 (fr) 2018-05-31
SG11201510021TA (en) 2016-01-28
EA201690050A1 (ru) 2016-05-31
WO2014202723A1 (en) 2014-12-24
US20160136303A1 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
BR112015031977A2 (pt) gel biocompatível, e, kit
BR112015015287A2 (pt) formulação e dispositivo indicador de ph
BR112015001898A2 (pt) sistema para identificar artefatos de movimentação; e método para identificar artefatos de movimentação
BR112016028958A2 (pt) método in vitro para diagnóstico de osteoporose ou determinação do risco de fraturas osteoporóticas ou monitoramento do tratamento em um indivíduo compreendendo as etapas de coleta de amostra de sangue, de medição do nível de micrornas e de comparação do nível de mirnas com o nível da amostra de referência e composição para tratamento
BR112017017631A2 (pt) polímero à base de dieno conjugado modificado e método para produzir o mesmo, composição de borracha e pneu
WO2015071876A3 (en) Use of microrna markers for diagnosis of thyroid tumors and a diagnostic panel containing such markers.
EP2113219A3 (en) Reprocessing indicator for single patient use medical instruments
CR20120264A (es) Compuestos
BR112018006680A2 (pt) supressor contendo nanomaterial conjugado por polímero solúvel em água e uso do mesmo
BR112012000311A8 (pt) Nanocristais com base em ouro para tratamentos médicos e processos eletroquímicos para a fabricação dos mesmos
BR112016007960A8 (pt) método para obter uma proporção de aldosterona para angiotensina ii (aa2r)
BR112015027757A2 (pt) elastômeros parcialmente fluorados e métodos para a produção e uso dos mesmos
BR112015031984A2 (pt) gel biocompatível compreendendo nanopartículas e/ou agregados de nanopartículas; e kit compreendendo um gel biocompatível
UY35993A (es) Prolinas / piperidinas sustituidas como antagonistas del receptor de orexina
BR112015022982A2 (pt) inibidores macrocíclicos de rip2 quinase
BR112016013881A2 (pt) Membro para interface com um paciente, e interface com um paciente para a liberação de gás para um usuário
BR112018012218A2 (pt) preparação de liberação prolongada de apremilast
BR112018069901A2 (pt) aduto de ciclodextrina-panobinostat
BR112014015841A2 (pt) composição de resina alquídica compreendendo sílica
BR112016010351A2 (pt) Composições em forma de pó, métodos de produção de uma composição em forma de pó, preparação farmacêutica, e artigo médico
BR112015027249A2 (pt) método de diagnóstico de câncer
AR091278A1 (es) PROCESO PARA LA FABRICACION DE POLVO DE ESCAYOLA b-HEMIHIDRATADA ESTABILIZADA Y POLVO OBTENIDO
BR112014025994A2 (pt) método para diagnóstico da osteoporose utilizando um método para determinação da dinâmica de fechamento de cavidades para avaliar a eficácia do uso de vários protetores ósseos
BR112015018555A2 (pt) placa de tratamento para um aparelho de tratamento de peça de vestuário, aparelho de tratamento de peça de vestuário, e, método para produzir um revestimento sobre uma superfície de contato de uma placa de tratamento para um aparelho de tratamento de peça de vestuário
BR112016004374A2 (pt) “dispositivo de diagnóstico para a detecção de estruturas alvo relacionadas a doenças”

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A61K 9/51 (2006.01), A61K 9/08 (2006.01), A61K 47/

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]